کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
4279590 1611524 2012 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Assessment of mitotic rate reporting in melanoma
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی عمل جراحی
پیش نمایش صفحه اول مقاله
Assessment of mitotic rate reporting in melanoma
چکیده انگلیسی

BackgroundIn patients with cutaneous melanoma, mitotic rate (MR) historically has been reported as the number of mitoses per high-power field (hpf) or per 10 hpf. The most recent revision of the American Joint Committee on Cancer melanoma staging system now incorporates MR and specifies that MR should be reported as mitoses per mm2, with a conversion factor of 1 mm2 equaling 4 hpf. However, because many pathologists continue to report MR in hpf units, we sought to compare the 2 conventions for reporting MR; this is important now that MR is used for staging and prognostic information.MethodsA retrospective analysis was performed of a database that combined patients from a large multicenter study and our single-institution melanoma database. All patients with pathology reports that included MR were included. For patients with MR reported in hpf units, MR was converted to mitoses per 10 hpf. Statistical analysis was performed to test differences in Breslow thickness (BT), ulceration, sentinel lymph node (SLN) status, and overall survival (OS) (log-rank test) between the mitoses per mm2 group versus the mitoses per 10-hpf group.ResultsA total of 1,148 patients were identified; of these, 759 were reported as per mm2 and 389 were reported in hpf units. When patients were subdivided into categories of MR of 0, 1, or more than 1, there was no statistically significant difference in mean or median BT, ulceration, or SLN positivity within categories between patients with MR per mm2 versus patients with MR reported per 10 hpf. There was also no difference in OS between groups. Subdividing into smaller categories of MR of 0, 1, 2, 3, 4, 5, or more than 5 did not yield different results.ConclusionsAlthough the American Joint Committee on Cancer staging system reports a conversion factor for MR of 1 mm2 equals 4 hpf, no clinically meaningful differences in predictors of prognosis (BT, ulceration, SLN positivity) or OS were seen between groups when a conversion factor of 1 mm2 equaling 10 hpf was used. Therefore, for practical purposes, MR reported per 10 hpf approximates MR per mm2.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: The American Journal of Surgery - Volume 204, Issue 6, December 2012, Pages 969–975
نویسندگان
, , , , , , , , ,